Omeros stock fell 13.78 percent on Nasdaq on October 16, 23.70 percent below its high

Published on 10/17/2026 at 18:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Omeros stock closed at USD 16.20 on October 16, 2026, down 13.78 percent on Nasdaq. Volume reached 3.96 million shares, 2.30 times its average.

Trading range and dates

On October 16, 2026, Nasdaq trading sent Omeros stock down 13.78 percent.
Volume reached 3.96 million shares, or 2.30 times the average.
Omeros stock closed at USD 16.20 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 13.78 percent versus the prior close of USD 18.79.
Omeros is scheduled to report earnings on November 12, 2026.

OMER, US6821431029, Illustration mit AI erstellt.

Omeros stock (ISIN US6821431029) fell 13.78 percent on Nasdaq on October 16, 2026, ending 23.70 percent below its 52-week high. The decline came with 3.96 million shares traded, 2.30 times average volume. The closing price was USD 16.20 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 13.78 percent from USD 18.79.

Trading volume magnifies the decline

The session range ran from USD 15.85 to USD 17.94, putting the close USD 5.04 below the 52-week high of USD 21.24. The stock remained USD 9.96 above its 52-week low of USD 6.24, while its year-to-date performance stood at minus 5.70 percent.

Volume was the clearest market signal. Omeros traded 3.96 million shares against an average of 1.74 million, a 2.30-times ratio that marked a much busier session than usual.

Valuation and the next reporting date

Omeros had a market capitalization of USD 1.2 billion as of October 16, 2026. Its trailing P/E ratio was 9.42, while the company paid no dividend yield according to the same market snapshot.

MarketBeat listed a consensus price target of USD 30.33 from five analysts on October 16, 2026. The target stood USD 14.13 above the Nasdaq close of USD 16.20.

MetaCap listed November 12, 2026 as Omeros's next earnings date. The scheduled report will give investors a new reference point after the October 16 decline.

Comparison with peers

The comparison below uses October 16, 2026 closing figures.
Omeros (NASDAQ, USD): minus 13.78 percent, P/E 9.42, market capitalization USD 1.2 billion
BioMarin Pharmaceutical (Nasdaq, USD): minus 2.44 percent, P/E 140.21, market capitalization USD 10.6 billion
Ultragenyx Pharmaceutical (Nasdaq, USD): minus 4.15 percent, P/E minus 2.49, market capitalization USD 1.4 billion

Nasdaq close sets the baseline

Omeros ended regular Nasdaq trading at USD 16.20 on October 16, 2026 at 4:00 p.m. ET, down 13.78 percent from the prior close of USD 18.79. The close sat within the USD 6.24 to USD 21.24 52-week range, with the next earnings date set for November 12, 2026.